Ensysce Biosciences (ENSCW) Return on Sales (2020 - 2025)
Historic Return on Sales for Ensysce Biosciences (ENSCW) over the last 6 years, with Q3 2025 value amounting to 7.6%.
- Ensysce Biosciences' Return on Sales fell 77900.0% to 7.6% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.46%, marking a year-over-year decrease of 6700.0%. This contributed to the annual value of 1.54% for FY2024, which is 34200.0% up from last year.
- According to the latest figures from Q3 2025, Ensysce Biosciences' Return on Sales is 7.6%, which was down 77900.0% from 1.28% recorded in Q2 2025.
- Ensysce Biosciences' Return on Sales' 5-year high stood at 0.19% during Q3 2024, with a 5-year trough of 34.19% in Q2 2022.
- Its 5-year average for Return on Sales is 7.65%, with a median of 4.68% in 2023.
- As far as peak fluctuations go, Ensysce Biosciences' Return on Sales tumbled by -312100bps in 2022, and later soared by 295100bps in 2023.
- Quarter analysis of 5 years shows Ensysce Biosciences' Return on Sales stood at 1.23% in 2021, then crashed by -253bps to 4.36% in 2022, then crashed by -56bps to 6.8% in 2023, then skyrocketed by 60bps to 2.75% in 2024, then crashed by -176bps to 7.6% in 2025.
- Its Return on Sales was 7.6% in Q3 2025, compared to 1.28% in Q2 2025 and 1.49% in Q1 2025.